Article ISI
Diabetes, Obesity and Metabolism  (2018)

Design and baseline characteristics of participants in the Researching cardiovascular Events with a Weekly INcretin in Diabetes (REWIND) trial on the cardiovascular effects of dulaglutide

Gerstein, HC; Colhoun, HM; Dagenais, GR; Diaz, R; Lakshmanan, M; Pais, P; Probstfield, J; Riddle, MC; Ryden, L; Xavier, D; Atisso, CM; Avezum, A; Basile, J; Chung, N; Conget, I; Cushman, WC; Franek, E; Hancu, N; Hanefeld, M; Holt, S; Jansky, P; Keltai, M; Lanas, F; Leiter, LA; Lopez-Jaramillo, P; Cardona-Munoz, EG; Pirags, V; Pogosova, N; Raubenheimer, PJ; Shaw, J; Sheu, WHH; Temelkova-Kurktschiev, T